U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Fallntolol is a beta-adrenergic receptor antagonist. Falintolol does not produce any noteworthy side effects and is capable of being an effective beta-blocking agent in open-angle glaucoma therapy.

Originator

Curator's Comment: reference retrieved from https://link.springer.com/chapter/10.1007/978-1-4757-2085-3_6

Approval Year

PubMed

PubMed

TitleDatePubMed
Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers.
1984 Oct
In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the cornea.
1985 Apr
Determination of falintolol, a new aliphatic beta-adrenergic antagonist, in whole blood by gas chromatography with electron-capture detection: geometric isomers resolution.
1987 Jan
Substance Class Mixture
Created
by admin
on Sat Dec 16 19:28:46 GMT 2023
Edited
by admin
on Sat Dec 16 19:28:46 GMT 2023
Record UNII
8ZG1XG255D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FALINTOLOL OXALATE
Common Name English
FALINTOLOL OXALATE, (±)-
Common Name English
ETHANONE, 1-CYCLOPROPYL-, O-(3-((1,1-DIMETHYLETHYL)AMINO)-2-HYDROXYPROPYL)OXIME, ETHANEDIOATE (1:1) (SALT)
Systematic Name English
Code System Code Type Description
FDA UNII
8ZG1XG255D
Created by admin on Sat Dec 16 19:28:46 GMT 2023 , Edited by admin on Sat Dec 16 19:28:46 GMT 2023
PRIMARY
CAS
99051-41-9
Created by admin on Sat Dec 16 19:28:46 GMT 2023 , Edited by admin on Sat Dec 16 19:28:46 GMT 2023
ALTERNATIVE
CAS
88134-93-4
Created by admin on Sat Dec 16 19:28:46 GMT 2023 , Edited by admin on Sat Dec 16 19:28:46 GMT 2023
PRIMARY
All of the following components must be present:
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
Definition References